And the decreased LPL activity has been identified to be caused by secondary hyperparathyroidism induced insulin resistance (IR) and excess of lipase inhibitors like apolipoprotein (Apo) C-III in the progression of CKD [56, 57]. The gene discussed is LPL; the disease is chronic kidney disease.